East Africa Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Country 2024-2032

East Africa Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Country 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A16120
Buy Now

Market Overview:

East Africa vaccine market size is projected to exhibit a growth rate (CAGR) of 5.8% during 2024-2032. The growing awareness about the importance of vaccines in averting infectious diseases, rising development of advanced technologies, including messenger ribonucleic acid (mRNA) and viral vector platforms, and increasing investments in immunization programs represent some of the key factors driving the market.

Report Attribute
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Growth Rate (2024-2032) 5.8%


A vaccine represents a biological formulation strategically made to activate the immune system of an individual, prompting it to mount a robust defense against specific disease-causing agents. It encompasses a diverse array, such as live attenuated vaccines like the Measles, Mumps, and Rubella (MMR) vaccine, which utilize weakened live pathogens to trigger an immune response. It also consists of inactivated vaccines, as seen with the polio vaccine, which employ killed pathogens or their constituent parts to stimulate immunity. It is available as subunit, recombinant, or conjugate vaccines, which harness isolated portions of the pathogen, such as proteins or sugars, to elicit an immune reaction. It undergoes meticulous clinical trials and rigorous regulatory scrutiny to ensure it adheres to stringent safety standards before gaining approval for use. It is administered to patients for maximizing protection against diseases at different stages of life. It not only saves countless lives by preventing infections but also minimizes the risk of complications stemming from various diseases. It acts as a formidable shield, safeguarding individuals from debilitating and potentially fatal diseases, consequently paving the way for healthier and extended lifespans. It helps to build herd immunity generated through widespread vaccination. It is instrumental in preventing outbreaks and serves as a vital component of public health strategy, substantially reducing the overall burden of infectious diseases.

East Africa Vaccine Market Trends:

At present, the increasing emphasis on preventive healthcare, driven by the growing awareness about the importance of vaccines in averting infectious diseases, represents one of the crucial factors impelling the growth of the market in East Africa. Besides this, the rising development of advanced vaccine technologies, including messenger ribonucleic acid (mRNA) and viral vector platforms, enabling rapid responses to emerging threats is contributing to the market growth in the region. Regulatory agencies are also streamlining approval processes to expedite vaccine development and deployment. In addition, there is a growing need for vaccines to protect adults from various diseases, including influenza, shingles, and pneumococcal infections. Chronic conditions and autoimmune disorders are becoming more prevalent, prompting research into therapeutic vaccines that could help prevent or treat these diseases. Apart from this, increasing risks of disease transmission and outbreaks, especially among individuals living in urban and over-crowded areas, are leading to the introduction of comprehensive immunization and vaccination programs in the region. Additionally, companies are also exploring novel business models, such as public-private partnerships and advanced purchase agreements, to ensure the affordability and accessibility of vaccines while maintaining profitability.

East Africa Vaccine Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the regional and country levels for 2024-2032. Our report has categorized the market based on product type, treatment type, technology, route of administration, patient type, indication, distribution channel, and end user.

Product Type Insights:

  • Multivalent Vaccine
  • Monovalent Vaccine
     

The report has provided a detailed breakup and analysis of the market based on the product type. This includes multivalent vaccine and monovalent vaccine.

Treatment Type Insights:

  • Preventive Vaccine
  • Therapeutic Vaccine
     

A detailed breakup and analysis of the market based on the treatment type have also been provided in the report. This includes preventive vaccine and therapeutic vaccine.

Technology Insights:

  • Conjugate Vaccines
  • Inactivated and Subunit Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines
  • Others
     

The report has provided a detailed breakup and analysis of the market based on the technology. This includes conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, toxoid vaccines, and others.

Route of Administration Insights:

  • Intramuscular and Subcutaneous Administration
  • Oral Administration
  • Others
     

A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes intramuscular and subcutaneous administration, oral administration, and others.

Patient Type Insights:

  • Pediatric
  • Adult
     

The report has provided a detailed breakup and analysis of the market based on patient type. This includes pediatric and adult.

Indication Insights:

  • Bacterial Diseases
    • Meningococcal Disease
    • Pneumococcal Disease
    • Diphtheria/Tetanus/Pertussis (DPT)
    • Tuberculosis
    • Haemophilus Influenzae (Hib)
    • Typhoid
    • Others
  • Viral Diseases
    • Hepatitis
    • Influenza
    • Human Papillomavirus (HPV)
    • Measles/Mumps/Rubella (MMR)
    • Rotavirus
    • Herpes Zoster
    • Varicella
    • Japanese Encephalitis
    • Rubella
    • Polio
    • Rabies
    • Dengue
    • Others
       

A detailed breakup and analysis of the market based on the indication have also been provided in the report. This includes bacterial diseases (meningococcal disease, pneumococcal disease, diphtheria/tetanus/pertussis (DPT), tuberculosis, haemophilus influenzae (Hib), typhoid, others) and viral diseases (hepatitis, influenza, human papillomavirus (HPV), measles/mumps/rubella (MMR), rotavirus, herpes zoster, varicella, Japanese encephalitis, rubella, polio, rabies, dengue, and others).

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Institutional Sales
  • Others
     

The report has provided a detailed breakup and analysis of the market based on distribution channel. This includes hospital pharmacies, retail pharmacies, institutional sales, and others.

End User Insights:

  • Hospitals
  • Clinics
  • Vaccination Centers
  • Academic and Research Institutes
  • Others
     

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, clinics, vaccination centers, academic and research institutes, and others.

Country Insights:

  • Ethiopia
  • Kenya
  • Tanzania
  • Uganda
  • Sudan
  • Rwanda
  • Others
     

The report has also provided a comprehensive analysis of all the major regional markets, which include Ethiopia, Kenya, Tanzania, Uganda, Sudan, Rwanda, and Others.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

East Africa Vaccine Market Report Coverage:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: 
  • Product Type
  • Treatment Type
  • Technology
  • Route of Administration
  • Patient Type
  • Indication
  • Distribution Channel
  • End User
  • Country
Product Types Covered Multivalent Vaccine, Monovalent Vaccine
Treatment Types Covered Preventive Vaccine, Therapeutic Vaccine
Technologies Covered Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Others
Route of Administrations Covered Intramuscular and Subcutaneous Administration, Oral Administration, Others
Patient Types Covered Pediatric, Adult
Indications Covered
  • Bacterial Diseases: Meningococcal Disease, Pneumococcal Disease, Diphtheria/Tetanus/Pertussis (DPT), Tuberculosis, Haemophilus Influenzae (Hib), Typhoid, Others
  • Viral Diseases: Hepatitis, Influenza, Human Papillomavirus (HPV), Measles/Mumps/Rubella (MMR), Rotavirus, Herpes Zoster, Varicella, Japanese Encephalitis, Rubella, Polio, Rabies, Dengue, Others
Distribution Channels Covered Hospital Pharmacies, Retail Pharmacies, Institutional Sales, Others
End Users Covered Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, Others
Countries Covered Ethiopia, Kenya, Tanzania, Uganda, Sudan, Rwanda, Others
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the East Africa vaccine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the East Africa vaccine market?
  • What is the breakup of the East Africa vaccine market on the basis of product type?
  • What is the breakup of the East Africa vaccine market on the basis of treatment type?
  • What is the breakup of the East Africa vaccine market on the basis of technology?
  • What is the breakup of the East Africa vaccine market on the basis of route of administration?
  • What is the breakup of the East Africa vaccine market on the basis of patient type?
  • What is the breakup of the East Africa vaccine market on the basis of indication?
  • What is the breakup of the East Africa vaccine market on the basis of distribution channel?
  • What is the breakup of the East Africa vaccine market on the basis of end user?
  • What are the various stages in the value chain of the East Africa vaccine market? 
  • What are the key driving factors and challenges in the East Africa vaccine?
  • What is the structure of the East Africa vaccine market and who are the key players?
  • What is the degree of competition in the East Africa vaccine market?

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the East Africa vaccine market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the East Africa vaccine market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the East Africa vaccine industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
East Africa Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Country 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More